Clinical Trial Update: Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two enoxaparin regimens for thromboprophylaxis in hospitalized obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Thromboprophylaxis in Hospitalized Obese Patients | Phase 3 | Status: COMPLETED